Tissue 2015 - 2nd Tissue Models & Phenotypic Screening Conference

2nd Tissue Models & Phenotypic Screening Conference, which will take place on May 5 - 7, 2015 in Berlin, Germany.
Over the years, three-dimensional (3D) models have become more favored over two-dimensional models (2D) because they better mimic the in vivo environment. Though 3D models have the potential to reduce failure in early stage drug discovery, there are still many questions to be answered: What are the gaps that still exist between 3D and 2D models? How will we conduct research to fill those gaps and what technological developments are needed?
Sessions for the meeting include:
Human Tissue Engineered Models for Drug Development
Biomimetic In Vitro Models: Development, Structure, and Function
In-Vivo 3D Models for Drug Safety Testing (Toxicology) and Screening
Phenotypic Screening with Functional Analysis Including Complex Models
Target Identification & Target Fishing After a Phenotypic Screen
Phenotypic Screening for Target Deconvolution (joint session with parallel Drug Design & Medicinal Chemistry Conference)
Advances in Phenotypic Screening and Functional Analysis
Case Studies in Phenotypic Screening
High Content Analysis of Tumor Spheroid Models
Developing Physiologically Relevant Models: 2D, Tissue, and Organ System Models